Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis

Annals of Neurology

Volumn 67, Issue 5, 2010, Pages 625-638

  Correale, Jorge ^a   Villa, Andrés ^b  

^a FLENI   (Argentina)

^b HOSPITAL RAMOS MEJÍA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CHEMOKINE RECEPTOR CCR7; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; JANUS KINASE 2; KYNURENINE; L SELECTIN; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONE; CELL CLONING; CELL CONTACT; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; DISEASE EXACERBATION; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REMISSION;

ADULT; ANTIGENS, CD4; ANTIGENS, CD8; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LOGISTIC MODELS; MALE; MULTIPLE SCLEROSIS; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY;

EID: 77951712594     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21944     Document Type: Article

References (47)

1. McFarland HF, Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 2007;8:913-919. (Pubitemid 47300005)
2. Bouneaud C, Kourilsky P, Bousso P. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 2000;13:829-840. (Pubitemid 32041805)
3. Falb D, Briner TJ, Sunshine GH, et al. Peripheral tolerance in T cell receptor-transgenic mice: evidence for T cell anergy. Eur J Immunol 1996;26:130-135. (Pubitemid 26028423)
4. Critchfield JM, Racke MK, Zúñiga-Pflücker JC, et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994;263:1139-1143.
5. Ferber I, Schönrich G, Schenkel J, et al. Levels of peripheral tolerance induced by different doses of tolerogen. Science 1994;263:674-676. (Pubitemid 24076292)
6. Buer J, Lanoue A, Franzke A, et al. Interleukin 10 secretion and impaired effector function of major histocompatibilty complex class II restricted T cells anergized in vivo. J Exp Med 1998;187:177-183. (Pubitemid 28060433)
7. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004;199:971-979. (Pubitemid 38481088)
8. Antel J, Bania M, Noronha A, Neely S. Defective suppressor cell function mediated by T8+ cell lines from patients with progressive multiple sclerosis. J Immunol 1986;137:3436-3439. (Pubitemid 17193296)
9. Bania MB, Antel J, Reder AT, et al. Suppressor and cytolitic cell function in multiple sclerosis. Effects of cyclosporine and interleukin 2. J Clin Invest 1986;78:582-586. (Pubitemid 16074098)
10. Jiang H, Zhang SI, Pernis B. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 1992;256:1213-1215.
11. - mice. Science 1992;256:1210-1213.
12. Cohen IR. T-cell vaccination for autoimmune disease: a panorama. Vaccine 2001;20:706-710.
13. Zhang J, Medaer R, Stinissen, et al. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 1993;261:1451-1454. (Pubitemid 23334267)
14. Correale J, Lund B, McMillan M, et al. T cell vaccination in secondary progressive multiple sclerosis. J Neuroimmunol 2000;107:130-139. (Pubitemid 30347418)
15. Correale J, Villa A. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J Neuroimmunol 2008;195:121-134.
16. Correale J, McMillan M, McCarthy K, et al. Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neurology 1995;45:1370-1378.
17. Correale J, Farez M. Monocyte-derived dendritic cells in multiple sclerosis: the effect of bacterial infections. J Neuroimmunol 2007;190:177-189. (Pubitemid 47625616)
18. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002;3:737-747.
19. Widner B, Werner ER, Schennach H, et al. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997;43:2424-2426. (Pubitemid 28022985)
20. Laouar Y, Welte T, Fu XY, Flavell RA. STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 2003;19:903-912. (Pubitemid 37542309)
21. Wang T, Niu G, Kortylewski M, et al. Regulation of innate adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 2004;10:48-54. (Pubitemid 38524698)
22. Takeda K, Clausen BE, Kaisho T, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10:39-49. (Pubitemid 29077382)
23. Orabona C, Belladona ML, Vacca C, et al. Silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. J Immunol 2005;174:6582-6586. (Pubitemid 40705617)
24. Rifa'i M, Kawamoto Y, Nakashima I, Suzuki H. Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 2004;200:1123-1134.
25. Feger U, Tolosa E, Huang YH, et al. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 2007;110:568-577. (Pubitemid 47105395)
26. Najafian N, Chitnis T, Salama AD, et al. Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. J Clin Invest 2003;112:1037-1048.
27. Manavalan JS, Kim-Schulze S, Scotto L, et al. Alloantigen specific CD8+CD28-FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 2004;16:1055-1068.
28. Tang X, Maricic I, Purohit N, et al. Regulation of immunity by a novel population of Qa-1 restricted CD8alphaalpha+ TCRalphabeta+ T cells. J Immunol 2006;177:7645-7655.
29. Smith TRF, Kumar V. Revival of CD8+ Treg-mediated suppression. Trends Immunol 2008;29:337-342.
30. Tang X, Maricic I, Kumar V. Anti-TCR antibody treatment activates a novel population of nonintestinal CD8 alpha alpha+ TCR alpha beta+ regulatory T cells and prevents experimental autoimmune encephalomyelitis. J Immunol 2007;178:6043-6050. (Pubitemid 46717383)
31. Tang X, Marici I, Purohit N, et al. Regulation of immunity by a novel population of Qa-1-restrcited CD8 alpha alpha+ TCR alpha beta+ T cells. J Immunol 2006;177:7645-7655.
32. Chang CC, Ciubotariu R, Manavalan JS, et al. Tolerization of dendritic cells by T (S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002;3:237-243. (Pubitemid 34218114)
33. Izawa A, Yamaura K, Albin MJ, et al. A novel alloantigen-specific CD8+PD1+ regulatory T cell induced by ICOS-B7h blockade in vivo. J Immunol 2007;179:786-796.
34. Endarthi AT, Rifa'I M, Shi Z, et al. CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 2005;175:7093-7097.
35. Cosmi L, Liotta F, Lazzeri E, et al. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 2003;102:4107-4114.
36. Bisikirska B, Colgan J, Luban J, et al. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 2005;115:2904-2913.
37. Mahic M, Henjum K, Yaqub S, et al., Generation of highly suppressive adaptive CD8+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation. Eur J Immunol 2008;38:640-646.
38. Hahn BH, Singh RP, La Cava A, Ebling FM. Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant TGF-β secreting CD8+ T cell suppressors. J Immunol 2005;175:7728-7737. (Pubitemid 41713473)
39. Li J, Liu Z, Jiang S, et al. T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC. J Immunol 1999;163:6386-6392.
40. Takeda K, Clausen BE, Kaisho T, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10:39-49. (Pubitemid 29077382)
41. Gamero AM, Young HA, Wiltrout RH. Inactivation of Stat3 in tumor cells: releasing a brake on immune responses against cancer? Cancer Cell 2004;5:111-112.
42. Nefedova Y, Nagaraj S, Rosenbauer A, et al. Activation of dendritic cells via inhibition of Jak2/STAT3 signaling. J Immunol 2005;175:4338-4346. (Pubitemid 41361968)
43. Munn DH, Sharma MD, Lee JR, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002;297:1867-1870.
44. Meisel R, Zibert A, Laryea M, et al. Human bone marrow stromal cells inhibit allogenic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004;103:4619-4621. (Pubitemid 38745993)
45. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogenic fetal rejection by tryptophan catabolism. Science 1998;281:1191-1193. (Pubitemid 28406294)
46. Grohmann U, Orabona C, Fallarino F, et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002;3:1097-1101. (Pubitemid 35363664)
47. Grohmann U, Fallarino F, Bianchi R, et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 2003;198:153-160. (Pubitemid 36870195)